AKAN Stock Price & Analysis — Akanda Corp (Healthcare >> Drug Manufacturers - Specialty & Generic)
AKAN FAQ
What is AKAN's ROE?
Akanda Corp reports a Return on Equity (ROE) of 460.53%.
What is AKAN's dividend yield?
Akanda Corp offers a dividend yield of 0.00%.
What is AKAN's Quality Score?
Our AI rates AKAN's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy AKAN?
Our AI Timing Score for AKAN is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does AKAN belong to?
Akanda Corp is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange
AKAN AI Analysis Summary
Our AI summary for AKAN: Akanda Corp (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 0.00, ROE of 460.53%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 5.39
Price
0.08
(1.51%)
Day Change
|
|
|---|
AKAN, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 84 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.39 |
| PBV / Sector |
-0.24 / 9.54
|
| Earning Per Share | -93.22 |
| PE / Sector |
N/A / 28.71
|
| PEG or PE/Growth / Sector |
N/A / -0.10
|
| Average 1M Daily Value |
2.60 M
GREAT
|
| Average 1W Daily Value |
0.46 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
52% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-04 08:01:07 |
| Symbol | AKAN |
| Name | AKANDA CORP |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 0.54 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 2.87 / 10,605.93 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 100 King St. W, Toronto, ON, Canada, M5X 1G5
Phone: 416 862 7525
Website: https://www.akandacorp.com
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Top Related Stocks
Stocks in the Same Sector
Healthcare › Drug Manufacturers - Specialty & GenericAnalysed on the same criteria, ordered by market cap
Google